Skip to content
Fezakinumab
Fezakinumab is an antibody pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against interleukin-22.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
5 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Rheumatoid arthritisD001172EFO_0000685M06.9—1———1
Atopic dermatitisD003876EFO_0000274L20—1———1
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—2————2
PsoriasisD011565EFO_0000676L401————1
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameFEZAKINUMAB
INNfezakinumab
Description
Fezakinumab (human mab)
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID1007106-86-6
RxCUI—
ChEMBL IDCHEMBL1743017
ChEBI ID—
PubChem CID—
DrugBankDB12344
UNII ID0S77U25XZ3 (ChemIDplus, GSRS)
Target
Agency Approved
IL22
IL22
Organism
Homo sapiens
Gene name
IL22
Gene synonyms
ILTIF, ZCYTO18
NCBI Gene ID
50616
Protein name
interleukin-22
Protein synonyms
Cytokine Zcyto18, IL-10-related T-cell-derived inducible factor, IL-10-related T-cell-derived-inducible factor, IL-TIF
Uniprot ID
Q9GZX6
Mouse ortholog
—
—
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 161 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details